To include your compound in the COVID-19 Resource Center, submit it here.

INS37217 nasal spray: Began Phase I study

Inspire Pharmaceuticals Inc. (ISPH), Durham, N.C.

Read the full 65 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE